|
EXOC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.767700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.622900E-03 |
| Normal-vs-Stage2 |
1.110150E-01 |
| Normal-vs-Stage3 |
9.791600E-01 |
| Normal-vs-Stage4 |
7.018400E-01 |
| Stage1-vs-Stage2 |
9.941600E-01 |
| Stage1-vs-Stage3 |
5.844400E-03 |
| Stage1-vs-Stage4 |
5.417800E-03 |
| Stage2-vs-Stage3 |
1.111420E-01 |
| Stage2-vs-Stage4 |
7.813700E-02 |
| Stage3-vs-Stage4 |
7.248200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.712400E-02 |
| Normal-vs-AfricanAmerican |
3.710800E-01 |
| Normal-vs-Asian |
1.711390E-01 |
| Caucasian-vs-AfricanAmerican |
8.412000E-01 |
| Caucasian-vs-Asian |
6.123600E-01 |
| AfricanAmerican-vs-Asian |
5.578200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.729600E-01 |
| Normal-vs-Female |
9.898800E-03 |
| Male-vs-Female |
5.094200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.938600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.538050E-02 |
| Normal-vs-Age(61-80Yrs) |
2.037400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.883000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.355800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.124600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.810400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.530370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.642000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.453600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.26660000000045E-05 |
| Normal-vs-Grade 2 |
7.643900E-04 |
| Normal-vs-Grade 3 |
5.937400E-01 |
| Normal-vs-Grade 4 |
7.590100E-02 |
| Grade 1-vs-Grade 2 |
6.431600E-02 |
| Grade 1-vs-Grade 3 |
4.585700E-04 |
| Grade 1-vs-Grade 4 |
2.48309999999474E-05 |
| Grade 2-vs-Grade 3 |
8.409100E-04 |
| Grade 2-vs-Grade 4 |
1.67346999999651E-05 |
| Grade 3-vs-Grade 4 |
1.482080E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.15050000002193E-06 |
| Normal-vs-ccB subtype |
5.157800E-01 |
| ccA subtype-vs-ccB subtype |
2.19250000377258E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.674100E-02 |
| Normal-vs-N1 |
6.124200E-01 |
| N0-vs-N1 |
1.723800E-01 |
|
|
